ABVC BioPharma, Inc.
ABVC
$2.73
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.12% | 80.20% | 52.06% | 64.57% | 40.92% |
| Total Depreciation and Amortization | -34.73% | -12.99% | 5.97% | 2,028.47% | 2,110.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.95% | -93.26% | -18.92% | -46.09% | 4.50% |
| Change in Net Operating Assets | 7.27% | -142.63% | -175.84% | -126.08% | -113.42% |
| Cash from Operations | 40.61% | 70.56% | 64.43% | 66.19% | 12.32% |
| Capital Expenditure | -- | -- | -- | 100.00% | -371.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -66.45% | -47.96% | -47.96% | 39.73% | 80.42% |
| Cash from Investing | -58.07% | -39.26% | -39.26% | 41.88% | 79.42% |
| Total Debt Issued | 236.66% | 210.25% | 29.28% | -3.05% | -114.50% |
| Total Debt Repaid | -146.38% | -106.65% | 69.99% | 63.44% | 81.35% |
| Issuance of Common Stock | 116.81% | -37.84% | -77.05% | -84.31% | 365.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -105.44% | -84.51% | -79.05% | -- |
| Cash from Financing | -18.39% | -35.57% | -44.12% | -54.74% | 35.49% |
| Foreign Exchange rate Adjustments | 13.99% | -97.09% | -1,271.43% | -150.80% | -215.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66,620.00% | 108.88% | 121.78% | 58.66% | 100.02% |